BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 10803706)

  • 1. Myelomatous effusion with poor response to chemotherapy.
    Kim YM; Lee KK; Oh HS; Park SK; Won JH; Hong DS; Park HS; Park JS; Lee DW
    J Korean Med Sci; 2000 Apr; 15(2):243-6. PubMed ID: 10803706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasmocytic pleural effusion disclosing multiple myeloma].
    Elloumi M; Frikha M; Masmoudi H; Mseddi S; Ben Ayed M; Bouaziz M; Makni F; Souissi T
    Rev Mal Respir; 2000 Apr; 17(2):495-7. PubMed ID: 10859769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelomatous pleural effusion.
    Ghosh S; Gopal R; Advani SH
    J Assoc Physicians India; 2006 Sep; 54():738-9. PubMed ID: 17212026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelomatous pleural effusion.
    Gogia A; Agarwal PK; Jain S; Jain KP
    J Assoc Physicians India; 2005 Aug; 53():734-6. PubMed ID: 16398088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bence-Jones myeloma with pleural effusion: response to alpha-interferon and combined chemotherapy.
    Makino S; Yamahara S; Nagake Y; Kamura J
    Intern Med; 1992 May; 31(5):617-21. PubMed ID: 1504423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleural effusion as the first sign of multiple myeloma.
    Uskül BT; Türker H; Emre Turan F; Unal Bayraktar O; Melikoğlu A; Tahaoğlu C; Oz B
    Tuberk Toraks; 2008; 56(4):439-42. PubMed ID: 19123081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A multiple myeloma case presenting with bilateral pleural involvement].
    Yosunkaya S; Maden E; Toy H; Yazici R; Ozer F; Reisli I
    Tuberk Toraks; 2007; 55(3):285-9. PubMed ID: 17978927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked and sustained improvement of systemic sclerosis following polychemotherapy for coexistent multiple myeloma.
    Bachleitner-Hofmann T; Machold K; Knobler R; Drach J; Grumbeck E; Gisslinger H
    Clin Exp Rheumatol; 2002; 20(1):85-8. PubMed ID: 11892717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pleural effusion as a first sign of Ig D lambda multiple myeloma].
    Maachi M; Fellahi S; Diop ME; Francois T; Capeau J; Bastard JP
    Ann Med Interne (Paris); 2003 Feb; 154(1):70-2. PubMed ID: 12746663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of polychemotherapy (a VMCP/VCAP program) in multiple myeloma].
    Wutke K; Anger G
    Z Gesamte Inn Med; 1983 Dec; 38(23):630-3. PubMed ID: 6689459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytologic and flowcytometric findings in a case of myelomatous pleural effusion: A rare and ominous presentation of multiple myeloma.
    Hussain A; Khurana U; Vijayverghia G; Khurana AK; Goyal A; Tandon A
    Diagn Cytopathol; 2022 Feb; 50(2):E59-E62. PubMed ID: 34661377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloma with pleural involvement.
    Chen LM; Hwang WS
    Acta Cytol; 1991; 35(3):372-3. PubMed ID: 2042441
    [No Abstract]   [Full Text] [Related]  

  • 13. Myelomatous pleural effusion.
    Meoli A; Willsie S; Fiorella R
    South Med J; 1997 Jan; 90(1):65-8. PubMed ID: 9003828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelomatous pleural effusion in multiple myeloma- A rare presentation.
    Pradeep IY; Mayuri RK; Sourabh SP; Nirali MP
    J Cancer Res Ther; 2024 Jan; 20(1):476-478. PubMed ID: 38554369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple myeloma: VMCP/VBAP alternating combination chemotherapy is not superior to melphalan and prednisone even in high-risk patients.
    Boccadoro M; Marmont F; Tribalto M; Avvisati G; Andriani A; Barbui T; Cantonetti M; Carotenuto M; Comotti B; Dammacco F
    J Clin Oncol; 1991 Mar; 9(3):444-8. PubMed ID: 1999714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell kinetics and therapy in multiple myeloma: an update of the M83 protocol.
    Pileri A; Barbui T; Boccadoro M; Comotti B; Dammacco F; Gallamini A; Marmont F; Neretto G; Petrucci MT; Resegotti L
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():168-9. PubMed ID: 2713554
    [No Abstract]   [Full Text] [Related]  

  • 17. Response of vincristine, melphalan, cyclophosphamide and prednisolone in refractory multiple myeloma.
    Kabir AL; Rahman MJ; Begum M; Dipta TF; Baqui MN; Aziz A; Rahman F; Debnath RC; Habib MA
    Mymensingh Med J; 2012 Jan; 21(1):114-9. PubMed ID: 22314465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelomatous pleural effusion in a patient with plasmablastic myeloma: a case report.
    Chang H; Chou WC; Lee SY; Huang JY; Hung YH
    Diagn Cytopathol; 2009 Mar; 37(3):205-7. PubMed ID: 19170175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of multiple myeloma in stages II and III with melphalan, prednisone, cyclophosphamide, vincristine and BCNU (M-2 protocol)].
    Montalbán C; Sevilla F; Zapatero A; Blanco L; Sabán J; Serrano M; Serrano Ríos M
    Rev Clin Esp; 1985 May; 176(8):392-5. PubMed ID: 3839590
    [No Abstract]   [Full Text] [Related]  

  • 20. Unilateral pleural effusion as a presenting manifestation of plasma cell myeloma (multiple myeloma): a case report.
    Dharan M
    Acta Cytol; 2010; 54(5 Suppl):780-2. PubMed ID: 21053539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.